Geke A P Hospers Selected Research

Geke A P Hospers Research Topics

Disease

42	Neoplasms (Cancer) 12/2022 - 01/2002
37	Melanoma (Melanoma, Malignant) 12/2022 - 01/2003
20	Breast Neoplasms (Breast Cancer) 11/2022 - 11/2004
13	Neoplasm Metastasis (Metastasis) 11/2022 - 07/2011
12	Rectal Neoplasms (Rectal Cancer) 04/2022 - 03/2004
10	Esophageal Neoplasms (Esophageal Cancer) 07/2021 - 06/2013
8	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2018
5	Adenocarcinoma 01/2021 - 06/2013
5	Stomach Neoplasms (Stomach Cancer) 09/2018 - 06/2010
2	Carcinoma (Carcinomatosis) 04/2017 - 01/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 06/2013
2	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 11/2011
2	Colonic Neoplasms (Colon Cancer) 06/2013 - 05/2006
2	Vascular Diseases (Vascular Disease) 01/2007 - 02/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2005 - 09/2004
1	Lymphatic Metastasis 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Hepatitis 04/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Disease Progression 07/2019
1	Systemic Vasculitis 01/2018
1	Colitis 01/2018

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
12	Estrogen ReceptorsIBA 11/2022 - 02/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 01/2003
7	16-fluoroestradiolIBA 11/2022 - 01/2018
7	IpilimumabIBA 01/2022 - 11/2013
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020 - 05/2014
6	Estradiol (Delestrogen)FDA LinkGeneric 11/2022 - 10/2015
6	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2010
6	Pharmaceutical PreparationsIBA 01/2019 - 11/2004
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 01/2021
5	Capecitabine (Xeloda)FDA Link 01/2020 - 01/2005
5	VemurafenibIBA 01/2018 - 05/2013
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2018 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 12/2017
3	human ERBB2 proteinIBA 10/2020 - 12/2017
3	Carboplatin (JM8)FDA LinkGeneric 09/2018 - 08/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2018 - 08/2014
2	NivolumabIBA 01/2022 - 01/2022
2	Trastuzumab (Herceptin)FDA Link 10/2020 - 01/2020
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2018
2	Biological ProductsIBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2011
2	ParaffinIBA 01/2018 - 01/2015
2	GenisteinIBA 11/2017 - 04/2017
2	2- fluoro- 6- (6- hydroxynaphthalen- 2- yl)pyridin- 3- olIBA 11/2017 - 04/2017
2	Estrogens (Estrogen)FDA Link 04/2017 - 11/2016
2	Proto-Oncogene Proteins B-rafIBA 01/2017 - 04/2014
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2011
2	LigandsIBA 01/2015 - 11/2004
2	Bevacizumab (Avastin)FDA Link 01/2015 - 07/2011
2	Fluorouracil (Carac)FDA LinkGeneric 05/2006 - 01/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2005 - 01/2003
1	Trinitrotoluene (TNT)IBA 01/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 12/2021
1	Interleukin-2 (IL2)IBA 12/2021
1	antineoplaston A10 (A 10)IBA 09/2021
1	Programmed Cell Death 1 ReceptorIBA 04/2021
1	Dihydrotestosterone (Androstanolone)IBA 01/2021
1	AntibodiesIBA 01/2021
1	bicalutamide (Casodex)FDA LinkGeneric 01/2021
1	BMS-986192IBA 12/2020
1	AZD 6244IBA 12/2020
1	Lactate DehydrogenasesIBA 11/2020
1	GRB7 Adaptor ProteinIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	pertuzumabIBA 10/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	palbociclibIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	FluoridesIBA 01/2020
1	SodiumIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	ElementsIBA 11/2019
1	pembrolizumabIBA 07/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2018
1	Docetaxel (Taxotere)FDA Link 09/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	AndrogensIBA 12/2017
1	MitogensIBA 01/2017

Therapy/Procedure

32	Therapeutics 03/2022 - 08/2004
16	Radiotherapy 04/2022 - 03/2004
15	Chemoradiotherapy 04/2022 - 06/2013
13	Neoadjuvant Therapy 01/2022 - 11/2013
10	Drug Therapy (Chemotherapy) 04/2022 - 01/2003
3	Adjuvant Chemotherapy 01/2021 - 06/2013
2	Adjuvant Chemoradiotherapy 09/2018 - 01/2005
2	Esophagectomy 07/2016 - 02/2014
1	Combined Modality Therapy 04/2022
1	Duration of Therapy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Re-Irradiation 09/2021
1	Brachytherapy 01/2021
1	Immunotherapy 05/2020